Lv1
96 积分 2024-01-23 加入
Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial
22天前
已关闭
Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators
22天前
已关闭
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
28天前
已完结
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
1个月前
已完结
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
1个月前
已完结
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study
1个月前
已完结
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
3个月前
已完结
Upadacitinib for the treatment of refractory alopecia areata in pediatric patients: A retrospective study
3个月前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
9个月前
已完结
Kidney Transplantation: The Beauty and the Beast!
9个月前
已完结
皖公网安备34019202002308
